Gapping up
In reaction to strong earnings/guidance:
- LLNW +12.2%, NFLX +8%, ERIC +7.7%, AA +4.6% (also announced intent to pursue non-core asset sales), MS +4%, CSX +3.1%, TCBI +3%, KEY +2.6%, BBT +1.6%, UN +1.6%, PM +1.6%, TSM +1.3%, DOV +1.2%, STI +1.1%, CCI +0.8%, POOL +0.7%, .
Other news:
- TNDM +2.8% (announced publication of DCLP3 study data in the NEJM)
- AZN +0.9% (AstraZeneca and Daiichi Sankyo (DSNKY) announce that the FDA has accepted for review the Biologics License Application for [fam-] trastuzumab deruxtecan (DS-8201) and granted Priority Review)
- EGO +0.7% (reported preliminary Q3 gold production results)
- APA +0.6% (reported certain Q3 financial and operational results; reiterated Q3 production guidance), .
Analyst comments:
- TXMD +8.1% (initiated with a Buy at H.C. Wainwright)
- CRUS +1.7% (upgraded to Equal Weight from Underweight at Barclays)
- CDMO +1.4% (initiated with an Overweight at Stephens)
- SAM +0.9% (upgraded to Outperform from Market Perform at Cowen)